| MeSH term | MeSH ID | Detail |
|---|---|---|
| Mandibular Diseases | D008336 | 5 associated lipids |
| Bone Resorption | D001862 | 7 associated lipids |
| Foreign-Body Reaction | D005549 | 10 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Arthritis, Experimental | D001169 | 24 associated lipids |
| Bone Neoplasms | D001859 | 5 associated lipids |
| Fractures, Bone | D050723 | 4 associated lipids |
| Osteoarthritis | D010003 | 4 associated lipids |
| Carcinoma | D002277 | 18 associated lipids |
| Osteonecrosis | D010020 | 5 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mrozikiewicz-Rakowska B et al. | Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. | 2015 | J. Physiol. Pharmacol. | pmid:26579581 |
| Kurz K et al. | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. | 2015 | Dis. Markers | pmid:26576067 |
| Marley K et al. | Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL. | 2015 | Exp. Cell Res. | pmid:26254896 |
| McCarthy NI et al. | Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development. | 2015 | J. Immunol. | pmid:26254339 |
| Grosjean F et al. | Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. | 2015 | PLoS ONE | pmid:26247358 |
| Lewis JR et al. | Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. | 2015 | PLoS ONE | pmid:26222774 |
| Tanaka Y et al. | [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. | 2015 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:26016635 |
| Priyadarshi S et al. | Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. | 2015 | Ann. Hum. Genet. | pmid:25998045 |
| Yang Y et al. | The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. | 2015 | J. Biol. Chem. | pmid:25979341 |
| HaDuong JH et al. | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. | 2015 | Int. J. Cancer | pmid:25648303 |